Matrix Partners China Leads $14M Series C Round In Chinese Biotech Firm Lansionbio
Nanjing-based biotech firm Lansion Biotechnology (Lansionbio) has raised nearly RMB100 million (US$14 million) in a series C round of financing…
Nanjing-based biotech firm Lansion Biotechnology (Lansionbio) has raised nearly RMB100 million (US$14 million) in a series C round of financing…
Peijia Medical Co., Ltd, interventional medical products provider, announces on Wednesday that it has completed US$100 million in a series…
Naxions, a Chinese provider of digital marketing solutions for pharmaceutical companies, has completed a US$15 million series B round of…
Akeso Biopharma, an innovative biotechnology company, announced that it has raised nearly US$150 million in a series D funding round…
Yikon Genomics, a reproductive health-focused biotech firm, announces on Monday that it has completed RMB220 million (US$31.3 million) in a…
Denovo Biopharma, a Chinese biotechnology company providing a novel biomarker solution to personalize drug development, has raised RMB300 million (US$42.6…
I-Mab Biopharma, a Chinese-clinical stage biopharmaceutical company, has filed for an up to US$100 million IPO of American Depository Shares…
QnQuality Pharmaceuticals Ltd., a Shanghai-based drug R&D company, announces on Monday that it has raised US$15 million in a series…
Fountain Medical, a Chinese clinical-stage contract research organization (CRO) offering one-stop services to pharmaceutical and medical device companies, has raised…
China's non-invasive colon cancer screening biotech company, New Horizon Health Limited, announced in a signing ceremony that it had an…
Gene therapy start-up Exegenesis Bio Inc. has completed tens of millions of USD in a funding round led by K2…
dMed Biopharmaceutical Co., Ltd., a Chinese full service Clinical Contract Research Organization (CRO), announces on Wednesday that it has completed…
Internet-enabled medical platform Ming Yi Zhong He announces on Tuesday that it has raised more than RMB100 million (US$14 million)…
Ansun BioPharma, a China-US based clinical stage biopharmaceutical company, has raised US$80 million in a series B round of financing…
Chinese health management platform Genebox, also known as Jiyinbao has secured around RMB100 million (US$14 million) in a series A…
Gene+ Technology, providing gene testing service for cancer prevention, announced it raised RMB200 million (US$27.9 million) in a series B…
Shanghai-based oncotherapy-focused firm Hrain biotechnology Co., Ltd. announces on Monday that it raises RMB200 million (US$28 million) in a series…
Qihan Biotech, a Hangzhou-based biotech startup focused on organ transplantation, announced on Monday that it has raised US$25.5 million in…
AllinMD Orthopaedics Hospital, a Beijing-based Internet hospital has completed US$100 million in a series B round of financing. The deal…
Weiyun AI, a smart dental C2M (customer-to-manufacturer) startup announced on Wednesday that it has completed RMB100 million (US$14 million) in…
Ping An Global Voyager Fund, the venture investment arm of Ping An Insurance (Group) Company of China, Ltd., has led…
Chinese medical devices developer Stroke Medical announced this week that it has raised nearly RMB100 million (US$14.12 million) in a…
Insilico Medicine, a Hong Kong-based start-up specialized in next-generation artificial intelligence (AI) technology for drug discovery, has raised US$37 million…
GKHT Medical Technology, a Chinese company that wholesales and distributes medical supplies, has raised over RMB1.1 billion (US$154.39 million) in…
Leyue Health, a medical big data and health insurance technology service provider, has raised RMB115 million (US$16.12 million) in a…
Singaporean sovereign wealth fund Temasek Holdings and Chinese private equity firm Hillhouse Capital have acquired a 2% stake in Shenzhen-listed…
Yunhu Technology, an internet platform for primary medical service in China, has raised RMB220 million (US$30.73 million) in a series…
Huimei Technology, a Chinese artificial intelligence (AI)-powered medical solutions provider, has raised US$30 million in a series C round of…
Nuanwa Technology, a Chinese tech-driven start-up specialized in medical insurance services, has raised RMB100 million (US$13.95 million) in an angel…
HiFiBiO Therapeutics, a multinational biotherapeutics start-up that mobilizes the human immune system to combat disease, announced on Wednesday the completion…
Chinese X-ray imaging solutions provider XpectVision Technology has raised nearly 100 million (US$14.22 million) in a series B round of…